News About: R&D
Generic battle seen to be intensifying
With many global makers' blockbuster products coming off patent, the race for the generic drug market is set to be in full force in the second half of this year.
Last year, a total of 386 generic products were appr...
Korean researchers develop three oriental medicines
A team of Korean scientists developed three oriental medicines to combat Alzheimer’s cell dementia (LMK 02 and PM 012) and chronic renal failure (WHW), a breakthrough that may open new possibilities in the treatment o...
Kangwon Province, IVI to gear up for vaccine research
Gangwon Provincial Government said on September 15 that it signed a memorandum of understanding with the International Vaccine Institute for mutual collaboration on the research and development of vaccine projects.
...
Korean scientists facilitates development of DNA-based medicine
Viromed Co. says it administered VM202RY, DNA-based medicine for ischemic disease including peripheral and coronary artery disease, to the last patient in the phase I, dose-escalation study for 9 Korean patients.
T...
3 drugmakers involved in 7 biosimilar related projects
Three pharmaceutical firms – Kuhnil, Daewoong and Ildong – have been engaged in the local biosimilar business with seven research projects, according to a recent survey of 26 pharmaceutical firms conducted by the Kore...
Anyang City R&D center to attract pharmaceutical firms
To transform Anyang of Kyunggi Province into a research and development (R&D) hub, the city government plans to set up a R&D center for development of new drugs at a newly created site.
The center will accommodate ...
Study shows combining gene therapy and radiation holds promise
A novel approach that combines gene therapy and radiation therapy for treating prostate cancer has shown promising results for its safety and effectiveness, according to Dr. Kim Chae-ho, chief researcher of Radiation ...
IP-Korea opens R&D center
Institut Pasteur Korea (IP-Korea) has launched its independent research center on newly constructed on Pangyo Headquarters. The cost of construction was equally covered by the Minister of Education, Science and Techno...
LG Life Sciences to release new sustained-release formulations of human growth hormone
LG Life Sciences (LGLS) is expected to launch its home-grown sustained-release preparation of human growth hormone for treatment of SGA (small for gestational age) in Korea under the trade name Eutropine Plus.
Infa...
Novel oral cholera vaccine approved in India
A new low-cost oral cholera vaccine, which was jointly developed by the International Vaccine Institute (IVI) and Vietnamese manufacturer VaBiotech, has been licensed in India.
The vaccine could soon be made availa...
